Given the regulatory provisions (art. 6.1.a), art. 9.2.a) RGPD, in connection with Additional Provision 17a of the LOPDGDD) the explicit consent of the data subjects could enable the processing of data. The study may also be carried out with pseudonymous data, in accordance with subparagraph (d) of the said Additional Provision 17a. In any case, the principles and guarantees established in the data protection regulations, the aforementioned additional provision 17 and, where applicable, the Biomedical Research Act must be complied with. The communication of anonymous and aggregated information on the results of the operation carried out by the Foundation to the business fabric of the region would not be contrary to data protection regulations.